Society of Urologic Oncology (SUO)

Specialty Society


The Society of Urologic Oncology (SUO) at the AUA will address gaps in care for patients with urologic cancers.

Program Chairs:

Dr. Brian Cross and Dr. John Gore

Learning Objectives: 

  •   Discuss relevant biomarkers available for management of bladder cancer.    
  •   List possible new agents being considered for neoadjuvant therapy of urothelial cancer.    
  •   Review the quality of life and mental health impact of bladder cancer and its treatment.   
  •   Distinguish relevant medical, surgical, renal function, and QOL factors when evaluating complex RCC case with high risk for renal replacement.    
  •   Explain the integration of competing health risks into surgical decision-making for localized kidney cancer. 

4 AMA PRA Category 1 CreditsTM  

Continuing Medical Education